|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 131 - 140 of 657:
FDA Extends Review of Somaxon Pharmaceuticals' New Drug Application for Silenor by up to Three Months
Somaxon Pharmaceuticals, a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the trea...
Heart Health Begins Process to Obtain FDA Approval for Heart Health Monitor
Heart Health has announced that the Company has begun the process to obtain FDA approval for the Heart Health Monitor by engaging the services of Qual...
FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option. Johnson & Johnson Phar...
CIMTEK's Enhanced Magellon Software Eases FDA Compliance
CIMTEK, the market innovator's first choice for managing product quality, has announced an upgrade to its Magellon Quality Lifecycle Management (QLM) ...
Cook Medical Receives Conditional Approval from FDA to Begin Clinical Trial for Zenith Low Profile AAA Endovascular Graft
Cook Medical has received Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration (FDA) to begin a clin...
FDA Approves Low-dose Regimen of Premarin Vaginal Cream to Treat Moderate to Severe Postmenopausal D
PREMARIN (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new le...
ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve
STA Pharmaceuticals announced the Company filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Bepreve (bepotastine...
TNFerade Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
GenVec announced that TNFerade has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for its proposed use i...
Catapult Consultants Selected by FDA for User Fee Financial Operations Support
Catapult Consultants, a leader in financial management, program management and information technology services for federal agencies, has been selecte...
Celgene Cellular Therapeutics Receives FDA Clearance for First Placenta-Derived Stem Cell Clinical Study
Celgene Cellular Therapeutics (CCT), a wholly owned subsidiary of Celgene Corporation announced the U.S. Food and Drug Administration (FDA) has accept... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2010 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |